Ignite Creation Date:
2025-12-24 @ 11:56 PM
Ignite Modification Date:
2026-07-09 @ 6:59 AM
Study NCT ID:
NCT07243951
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-11-24
First Post:
2025-11-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II Clinical Study on the Efficacy and Safety of the Combination of Cadonilimab and Capecitabine in Adjuvant Therapy for Combined Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
Sponsor:
Shanghai Zhongshan Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
B2025-381R
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None